Suppr超能文献

重新审视比较有效性研究中观察性研究的问题、局限性和机遇。

Revisiting issues, drawbacks and opportunities with observational studies in comparative effectiveness research.

机构信息

Specialty Care Biostatistics, Pfizer Inc., New York, NY, USA.

出版信息

J Eval Clin Pract. 2013 Aug;19(4):579-83. doi: 10.1111/j.1365-2753.2011.01802.x. Epub 2011 Nov 29.

Abstract

RATIONALE

Despite their inherently pervasive limitations, data from observational studies are increasingly relied upon by health care decision makers to fill critical information gaps created by lack of evidence from randomized controlled trials.

AIM AND OBJECTIVE

The aim and objective of this article was to revisit the major issues associated with observational studies from secondary data sources.

METHOD

The method of this article was canvass of the literature.

RESULTS

Sources of bias are highlighted and steps intended to minimize bias are summarized.

CONCLUSION

Efforts should be made to improve causal inference of treatment effects from observational studies found in secondary data sources. Extra care and caution should be exercised in the interpretation and reporting of results from these studies.

摘要

理由

尽管观察性研究存在固有的局限性,但医疗保健决策者越来越依赖这些研究的数据来填补随机对照试验缺乏证据造成的关键信息空白。

目的和目标

本文的目的和目标是重新审视次要数据来源的观察性研究相关的主要问题。

方法

本文的方法是对文献进行综述。

结果

强调了偏倚的来源,并总结了旨在最小化偏倚的步骤。

结论

应努力提高从次要数据来源中观察性研究中治疗效果的因果推断。在解释和报告这些研究的结果时,应格外小心谨慎。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验